Thomas KH - Search Results

1

Leptomeningeal Disease and the Evolving Role of Molecular Targeted Therapy and Immunotherapy.

Thomas KH, Ramirez RA. Thomas KH, et al. Ochsner J. 2017 Winter;17(4):362-378. Ochsner J. 2017. PMID: 29230121 Free PMC article. Review.

2

Current and emerging strategies for the management of advanced/metastatic lung neuroendocrine tumors.

Rutherford M, Wheless M, Thomas K, Ramirez RA. Rutherford M, et al. Curr Probl Cancer. 2024 Apr;49:101061. doi: 10.1016/j.currproblcancer.2024.101061. Epub 2024 Jan 27. Curr Probl Cancer. 2024. PMID: 38281845 Review.

3

Work-Life Integration of Female Urologists.

Thomas K, Saltzman A, Hebert K, Montgomery M. Thomas K, et al. Urol Pract. 2018 Mar;5(2):143-149. doi: 10.1016/j.urpr.2017.02.011. Epub 2017 Mar 1. Urol Pract. 2018. PMID: 37300164

4

The Use of Eculizumab for the Treatment of Atypical Hemolytic Uremic Syndrome in an Academic Hematology Center.

Thomas K, Ananthula A, Lopez-Flores R, Toro AD, Chapple AG, Loch M. Thomas K, et al. Perm J. 2023 Jun 15;27(2):23-30. doi: 10.7812/TPP/22.073. Epub 2023 Jan 31. Perm J. 2023. PMID: 36718583 Free PMC article.

5

Nicotine receptor partial agonists for smoking cessation.

Livingstone-Banks J, Fanshawe TR, Thomas KH, Theodoulou A, Hajizadeh A, Hartman L, Lindson N. Livingstone-Banks J, et al. Among authors: thomas kh. Cochrane Database Syst Rev. 2023 May 5;5(5):CD006103. doi: 10.1002/14651858.CD006103.pub8. Cochrane Database Syst Rev. 2023. PMID: 37142273 Free PMC article. Review.

6

Who is accessing community lateral flow device testing and why? Characteristics and motivations of individuals participating in COVID-19 community testing in two English local authority areas.

Dalili MN, Long J, Wadley E, Sloan J, Cross A, Thomas KH, Morgan G. Dalili MN, et al. Among authors: thomas kh. BMC Public Health. 2022 Mar 25;22(1):588. doi: 10.1186/s12889-022-12986-4. BMC Public Health. 2022. PMID: 35337297 Free PMC article.

7

Using primary care databases for addiction research: An introduction and overview of strengths and weaknesses.

Kotz D, O'Donnell A, McPherson S, Thomas KH. Kotz D, et al. Among authors: thomas kh. Addict Behav Rep. 2022 Jan 13;15:100407. doi: 10.1016/j.abrep.2022.100407. eCollection 2022 Jun. Addict Behav Rep. 2022. PMID: 35111898 Free PMC article. Review.

8

Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis.

Thomas KH, Dalili MN, López-López JA, Keeney E, Phillippo D, Munafò MR, Stevenson M, Caldwell DM, Welton NJ. Thomas KH, et al. Health Technol Assess. 2021 Oct;25(59):1-224. doi: 10.3310/hta25590. Health Technol Assess. 2021. PMID: 34668482 Free article.

9

Comparative clinical effectiveness and safety of tobacco cessation pharmacotherapies and electronic cigarettes: a systematic review and network meta-analysis of randomized controlled trials.

Thomas KH, Dalili MN, López-López JA, Keeney E, Phillippo DM, Munafò MR, Stevenson M, Caldwell DM, Welton NJ. Thomas KH, et al. Addiction. 2022 Apr;117(4):861-876. doi: 10.1111/add.15675. Epub 2021 Oct 11. Addiction. 2022. PMID: 34636108 Free PMC article. Review.

10

Cost-Effectiveness Analysis of Smoking Cessation Interventions in the United Kingdom Accounting for Major Neuropsychiatric Adverse Events.

Keeney E, Welton NJ, Stevenson M, Dalili MN, López-López JA, Caldwell DM, Phillippo DM, Munafò MR, Thomas KH. Keeney E, et al. Among authors: thomas kh. Value Health. 2021 Jun;24(6):780-788. doi: 10.1016/j.jval.2020.12.012. Epub 2021 Mar 11. Value Health. 2021. PMID: 34119075 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

59 results

Search Page